연구성과로 돌아가기

2022 연구성과 (89 / 280)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
WoS SCOPUS Document Type Document Title Abstract Authors Affiliation ResearcherID (WoS) AuthorsID (SCOPUS) Author Email(s) Journal Name JCR Abbreviation ISSN eISSN Volume Issue WoS Edition WoS Category JCR Year IF JCR (%) FWCI FWCI Update Date WoS Citation SCOPUS Citation Keywords (WoS) KeywordsPlus (WoS) Keywords (SCOPUS) KeywordsPlus (SCOPUS) Language Publication Stage Publication Year Publication Date DOI JCR Link DOI Link WOS Link SCOPUS Link
Article Allogeneic hematopoietic cell transplantation can overcome the adverse prognosis indicated by secondary-type mutations in de novo acute myeloid leukemia Secondary-type mutations (STMs), namely SRSF2, SF3B1, U2AF1, ZRSR2, ASXL1, EZH2, BCOR, and STAG2, are more frequently detected in secondary acute myeloid leukemia (AML) than in de novo AML. Whether de novo AML with STMs should be differently managed is, however, unclear. In 394 patients diagnosed with de novo AML who had a normal karyotype, the genetic profiling via targeted deep sequencing of 45 genes revealed 59 patients carrying STMs (STM+). The STM+ group showed shorter overall survival (OS) than the STM- group (5-year OS, 15.3 vs. 31.0%) (hazard ratio [HR]: 1.975, 95% confidence interval [CI]: 1.446-2.699, p < 0.001). Among the 40 STM+ patients who achieved CR, those who received allogeneic HCT (n = 15) showed better OS (5-year OS, 40.0 vs. 12.0%) (HR: 0.423, 95% CI: 0.184-0.975, p = 0.043) and relapse-free survival (5-year, 40.0 vs. 8.0%) (HR: 0.438, 95% CI: 0.189-1.015, p = 0.054) than those who received consolidation chemotherapy only. The cumulative incidence of relapse was lower in the patients who received allogeneic HCT (5-year, 33.3 vs. 60.0%) (HR: 0.288, 95% CI: 0.111-0.746, p = 0.011), and non-relapse mortality was similar between the two groups (p = 0.935). In conclusion, STM is an independent prognostic factor for adverse outcomes in AML that can be overcome by allogeneic HCT. Song, Ga-Young; Kim, TaeHyung; Ahn, Seo-Yeon; Jung, Sung-Hoon; Kim, Mihee; Yang, Deok-Hwan; Lee, Je-Jung; Choi, Seung Hyun; Kim, Mi Yeon; Jung, Chul Won; Jang, Jun-Ho; Kim, Hee Je; Moon, Joon Ho; Sohn, Sang Kyun; Won, Jong-Ho; Park, Seong-Kyu; Kim, Sung-Hyun; Zhang, Zhaolei; Ahn, Jae-Sook; Kim, Hyeoung-Joon; Kim, Dennis Dong Hwan Chonnam Natl Univ, Hwasun Hosp, Hematol Oncol, Jeollanam Do, South Korea; Univ Toronto, Dept Comp Sci, Toronto, ON, Canada; Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; Chonnam Natl Univ, Hwasun Hosp, Genom Res Ctr Hematopoiet Dis, Jeollanam Do, South Korea; Samsung Med Ctr, Div Hematol Oncol, Seoul, South Korea; Catholic Univ Korea, Dept Hematol, Seoul, South Korea; Kyungpook Natl Univ Hosp, Dept Hematol Oncol, Daegu, South Korea; Soon Chun Hyang Univ Hosp, Dept Hematol Oncol, Seoul, South Korea; Dong A Univ, Coll Med, Dept Hematol Oncol, Busan, South Korea; Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; Univ Toronto, Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada Won, Jongho/AAM-8322-2021; Kim, Dennis/AAH-8499-2019; Kim, Hee-Je/O-3501-2019; Kim, Tae/O-4252-2015; Lee, Jung-Hye/F-6974-2013; Lee, Sang-Jun/A-3892-2015; Park, Jung Hyun/HJA-3755-2022 57193027251; 55763792349; 55945078500; 55511978300; 57218694093; 8701758000; 7601478211; 57203643100; 57904806900; 56405934800; 56470133700; 7410130758; 56568642700; 13310226800; 26434081600; 57077159400; 56547959500; 57203273189; 22984055900; 7410127473; 56312200900 f0115@chonnam.ac.kr;hjoonk@chonnam.ac.kr;dr.dennis.kim@uhn.ca; BONE MARROW TRANSPLANTATION BONE MARROW TRANSPL 0268-3369 1476-5365 57 12 SCIE HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION 2022 4.8 21.2 1.83 2025-06-25 15 15 CLASSIFICATION; DIAGNOSIS; THERAPY; ADULTS Disease-Free Survival; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Mutation; Prognosis; Recurrence; acute myeloid leukemia; adult; adverse outcome; aged; allogeneic hematopoietic stem cell transplantation; Article; cancer mortality; cancer prognosis; cancer survival; controlled study; female; gene sequence; human; major clinical study; male; overall survival; recurrence free survival; relapse; survival rate; acute myeloid leukemia; disease free survival; hematopoietic stem cell transplantation; mutation; prognosis; recurrent disease English 2022 2022-12 10.1038/s41409-022-01817-0 바로가기 바로가기 바로가기 바로가기
Meeting Abstract Allogeneic stem cell transplantation with 3-days busulfan plus fludarabine as conditioning regimen for patients with relapsed or refractory t- and nk/t-cell lymphomas Lee, J. H.; Yang, D. -H.; Jo, J. -C.; Lee, Y. J.; Lee, W. -S.; Choi, Y. S.; Moon, J. H.; Do, Y. R. Dong A Univ, Coll Med, Seogu, South Korea; Chonnam Natl Univ, Hwasun Hosp, Hwasun, South Korea; Univ Ulsan, Ulsan Univ Hosp, Coll Med, Ulsan, South Korea; Inje Univ, Busan Paik Hosp, Coll Med, Busan, South Korea; Ajou Univ, Sch Med, Suwon, South Korea; Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Daegu, South Korea; Keimyung Univ, Dongsan Med Ctr, Sch Med, Daegu, South Korea Jo, Jae-Cheol/CAE-9453-2022 BONE MARROW TRANSPLANTATION BONE MARROW TRANSPL 0268-3369 1476-5365 57 SUPPL 1 SCIE HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION 2022 4.8 21.2 0 English 2022 2022-11 바로가기 바로가기
Article Improvements in scintillation performance of Tl2LaCl5:5%Ce single crystals via Sr²⁺, Ba²⁺ and Ca²⁺ co-doping High detection efficiency for X- and gamma-rays, the possibility for fast neutron detection, and other excellent scintillation performances of Tl2LaCl5 (TLC) make it a potential radiation detector for applications in space exploration, medical imaging, homeland security, radiation monitoring, and nuclear and particle physics experiments. We evaluated the luminescence and scintillation performance of pure TLC and TLC doped with 5 mol% Ce (TLC:Ce) and co-doped with 5 mol% Ce and 0.2 mol% Ba, Ca, and Sr crystals, separately (TLC:Ce,Ba, TLC:Ce,Ca and TLC:Ce,Sr). The effect of co-doping on the luminescence and scintillation performance of TLC:Ce is studied for the 1st time. The room temperature radio- and photoluminescence shows characteristic Ce3+ luminescence for the Ce-doped and co-doped TLC crystals. We found that the co-doped crystals show improvement in terms of light yield, while improvement in the energy resolution and non-proportionality is observed in TLC co-doped with Ce and Sr. Khan, Arshad; Quoc Vuong, Phan; Daniel, D. Joseph; Kim, H. J.; Rooh, Gul; Luan, Nguyen Thanh Najran Univ, Promising Ctr Sensors & Elect Devices PCSED, POB 1988, Najran 11001, Saudi Arabia; Kyungpook Natl Univ, Dept Phys, Daegu 41566, South Korea; Abdul Wali Khan Univ, Dept Phys, Mardan 23200, Pakistan ; Khan, Arshad/ABB-1566-2021; Rooh, Gul/AAF-2076-2019; Kim, Hong Joo/AAE-1178-2022; Thanh Duong, Nguyen/AGY-4248-2022 56017063700; 57973579700; 55235066800; 59051568100; 24401665700; 57210576969 CRYSTENGCOMM CRYSTENGCOMM 1466-8033 24 46 SCIE CHEMISTRY, MULTIDISCIPLINARY;CRYSTALLOGRAPHY 2022 3.1 21.2 0.38 2025-06-25 5 5 GAMMA-RAYS; EFFICIENT SCINTILLATOR; HALIDE SCINTILLATOR; X-RAY; CE3+; DEPENDENCE; DETECTORS; TL2ZRCL6 Chlorine compounds; Doping (additives); Lanthanum compounds; Medical imaging; Neutron detectors; Neutron irradiation; Scintillation; Single crystals; Space research; Ca 2+; Ce-doped; Co-doped; Co-doping; Detection efficiency; Fast-neutron detection; Nuclear and particle physics; Radiation monitoring; Scintillation performance; Space explorations; Gamma rays English 2022 2022-11-29 10.1039/d2ce01124g 바로가기 바로가기 바로가기 바로가기
Article Synthesis, crystal growth, structural and physicochemical properties of an organic single crystal (C11H16N2O4) for fast scintillation and NLO applications 2-Amino-4-methyl pyridinium glutaric acid (2A4MGA) was synthesized and single crystals were grown from solution for the first time. From the single crystal X-ray diffraction (SCXRD) measurements, it was confirmed that the title compound crystallizes as a triclinic system and has a centrosymmetric nature with the space group P1. The calculated unit cell parameters are as follows: a = 7.1853(7) angstrom, b = 9.5314(9) angstrom, c = 11.0896(11) angstrom, alpha = gamma = 90 degrees, beta = 105.665(3)degrees and volume = 731.27(12) angstrom(3). The crystal structure was connected by the protonated 2-amino-4-methylpyridinium cations and the H-atoms in the carboxylic groups of the glutaric acid anions. The presence of various functional groups was studied, wherein the in-plane/out-of-plane stretching and symmetric/asymmetric vibrations were investigated through Fourier transform infrared (FT-IR) spectral analysis. From the thermogravimetric analysis (TGA) and differential scanning calorimetry (DSC) measurements, the thermal properties of the sample were investigated. The lower absorption edge was observed at 340 nm through UV-vis (ultraviolet-visible) spectral analysis, and the optical band gap was calculated to be 3.6 eV. The third-order optical susceptibility (chi((3))) of the sample was studied through the Z-scan spectra. Photoluminescence (PL) spectra for the grown crystal were recorded at room temperature and the peak emission was observed at 364 nm upon an excitation of 340 nm. The X-ray-induced emission spectrum shows a maximum peak at 364 nm. It has a fast scintillation decay time of 12 ns under gamma-ray excitation from a Cs-137 radiation source, which is comparable with that of currently available organic scintillators. The results suggest that this crystal can be used as an organic scintillator and in NLO applications. Daniel, D. Joseph; Karuppasamy, P.; Vuong, P. Q.; Kim, H. J. Kyungpook Natl Univ, Ctr High Energy Phys, Daegu 41566, South Korea; SSN Res Ctr, Kalavakkam 603110, Tamil Nadu, India ; Kim, Hong Joo/AAE-1178-2022; Pichan, Karuppasamy/N-5474-2017 35319662800; 59942562900; 57207618553; 59051568100 hongjoo@knu.ac.kr; CRYSTENGCOMM CRYSTENGCOMM 1466-8033 24 15 SCIE CHEMISTRY, MULTIDISCIPLINARY;CRYSTALLOGRAPHY 2022 3.1 21.2 0.46 2025-06-25 5 6 NONLINEAR-OPTICAL PROPERTIES; FLUORESCENCE; COCRYSTALS; DESIGN Crystal atomic structure; Crystal growth; Differential scanning calorimetry; Emission spectroscopy; Energy gap; Gamma rays; Ionization; Mass spectrometry; Physicochemical properties; Scintillation; Scintillation counters; Spectrum analysis; Thermogravimetric analysis; Vibration analysis; Glutaric acid; Grown from solutions; Organic scintillator; Organic single crystals; Physicochemical property; Pyridinium; Synthesised; Title compounds; Triclinic systems; X-ray diffraction measurements; Single crystals English 2022 2022-04-12 10.1039/d1ce01674a 바로가기 바로가기 바로가기 바로가기
Review Thallium-based heavy inorganic scintillators: recent developments and future perspectives The current development status and future perspectives of Tl-based inorganic scintillators are highlighted in this study. The thallium (Tl) ion is known to exhibit highly efficient luminescence in the widely used NaI:Tl+, CsI:Tl+, and recently discovered Cs2Cu3I5:Tl+ scintillators. Besides being an efficient luminescence center, Tl possesses high density and atomic number, so that its presence in the host material increases the density and effective atomic number of the scintillators, which provides higher efficiencies for high-energy X- and gamma-ray detection. Based on this idea, several novel efficient scintillators were reported by different research groups, which can be utilized in medical imaging, homeland security, space research, nuclear and high energy physics, rare event searches, and oil well logging. An overview of reported Tl-based scintillators and future directions for their improvements are discussed herein based on prior publications. Kim, HongJoo; Khan, Arshad; Daniel, Joseph; Rooh, Gul; Vuong, Phan Quoc Kyungpook Natl Univ, Dept Phys, Daegu 41566, South Korea; Abdul Wali Khan Univ, Dept Phys, Mardan 23200, Pakistan Kim, Hong Joo/AAE-1178-2022; Khan, Arshad/ABB-1566-2021; Rooh, Gul/AAF-2076-2019 59051568100; 56017063700; 36145005300; 24401665700; 57207618553 hongjoo@knu.ac.kr; CRYSTENGCOMM CRYSTENGCOMM 1466-8033 24 3 SCIE CHEMISTRY, MULTIDISCIPLINARY;CRYSTALLOGRAPHY 2022 3.1 21.2 0.84 2025-06-25 8 11 CRYSTAL-GROWTH; INTRINSIC SCINTILLATORS; EFFICIENT SCINTILLATOR; HALIDE SCINTILLATOR; FAST-NEUTRON; GAMMA-RAYS; X-RAY; CE3+; LUMINESCENCE; TL2ZRCL6 Atoms; Cesium iodide; Global positioning system; High energy physics; Iodine compounds; Ionization; Medical imaging; Oil well logging; Scintillation; Scintillation counters; Sodium Iodide; Space research; 'current; Atomic numbers; Development status; Effective atomic number; Future perspectives; Higher efficiency; Host materials; Inorganic scintillator; Luminescence centers; Thallium ions; Gamma rays English 2022 2022-01-18 10.1039/d1ce01422f 바로가기 바로가기 바로가기 바로가기
Article The microbial communities (bacteria, algae, zooplankton, and fungi) improved biofloc technology including the nitrogen-related material cycle in Litopenaeus vannamei farms Microbes are essential in biofloc technology for controlling nitrogen levels in water. The composition and function of microorganisms with biofloc systems were reported; however, data on microorganisms other than bacteria, such as algae (which are essential in the nitrogen cycle) and zooplankton (which are bacterial and algal predators), remain limited. The microbial communities (including bacteria, algae, zooplankton, and fungi) were investigated in shrimp farms using biofloc technology. Using Illumina MiSeq sequencing, the V4 region of 18S rRNA and the V3-V4 region of 16S rRNA were utilized for the analysis of the eukaryotic and prokaryotic microbial communities. As a result, it was found that the biofloc in the shrimp farm consisted of 48.73%-73.04% eukaryotic organisms and 26.96%-51.27% prokaryotic organisms. In these shrimp farms, prokaryotic microbial communities had higher specie richness and diversity than eukaryotic microbial communities. However, the eukaryotic microbial communities were more abundant than their prokaryotic counterparts, while algae and zooplankton dominated them. It was discovered that the structures of the microbial communities in the shrimp farms seemed to depend on the effects of predation by zooplankton and other related organisms. The results provided the nitrogen cycle in biofloc systems by the algal and bacterial groups in microbial communities. Yun, Hyun-Sik; Kim, Dong-Hyun; Kim, Jong-Guk; Kim, Young-Saeng; Yoon, Ho-Sung Kyungpook Natl Univ, Coll Nat Sci, Dept Biol, Daegu, South Korea; Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea; Kyungpook Natl Univ, Sch Life Sci & Biotechnol, BK21 Plus KNU Creat Biores Grp, Daegu, South Korea; Kyungpook Natl Univ, Res Inst Ulleung Do & Dok Do, Daegu, South Korea; Kyungpook Natl Univ, Adv Bioresource Res Ctr, Daegu, South Korea Kim, Dong Hyun/LDT-2672-2024 57215320824; 59444469900; 35277198800; 35798433500; 7402990205 kimjg@knu.ac.kr;kyslhh1228@hanmail.net;hsy@knu.ac.kr; FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY FRONT BIOENG BIOTECH 2296-4185 10 SCIE MULTIDISCIPLINARY SCIENCES 2022 5.7 21.2 1.4 2025-06-25 13 15 biofloc technology; illumina MiSeq; microbial community; shrimp farm; zoo plankton DNA EXTRACTION; GREEN-ALGAE; SHRIMP; AQUACULTURE; DIVERSITY; GROWTH; AMMONIA; PROTEIN; OSCILLATORIA; INOCULATION biofloc technology; illumina MiSeq; microbial community; shrimp farm; zoo plankton Bacteria; Fungi; Nitrogen; RNA; Bio-flocs technologies; Bioflocs; Eukaryotics; Illumen miseq; Illumina; Microbial communities; Nitrogen cycles; Prokaryotics; Shrimp farm; Zoo-plankton; Algae English 2022 2022-11-23 10.3389/fbioe.2022.883522 바로가기 바로가기 바로가기 바로가기
Review CAR T-Cell-Based gene therapy for cancers: new perspectives, challenges, and clinical developments Chimeric antigen receptor (CAR)-T cell therapy is a progressive new pillar in immune cell therapy for cancer. It has yielded remarkable clinical responses in patients with B-cell leukemia or lymphoma. Unfortunately, many challenges remain to be addressed to overcome its ineffectiveness in the treatment of other hematological and solidtumor malignancies. The major hurdles of CAR T-cell therapy are the associated severe life-threatening toxicities such as cytokine release syndrome and limited anti-tumor efficacy. In this review, we briefly discuss cancer immunotherapy and the genetic engineering of T cells and, In detail, the current innovations in CAR T-cell strategies to improve efficacy in treating solid tumors and hematologic malignancies. Furthermore, we also discuss the current challenges in CAR T-cell therapy and new CAR T-cell-derived nanovesicle therapy. Finally, strategies to overcome the current clinical challenges associated with CAR T-cell therapy are included as well. Jogalekar, Manasi P.; Rajendran, Ramya Lakshmi; Khan, Fatima; Dmello, Crismita; Gangadaran, Prakash; Ahn, Byeong-Cheol Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA; Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Nucl Med, Daegu, South Korea; Northwestern Univ, Feinberg Sch Med, Dept Neurol Surg, Chicago, IL USA; Kyungpook Natl Univ, Sch Med, Dept Biomed Sci, BK21 FOUR KNU Convergence Educ Program Biomed Sci, Daegu, South Korea Gangadaran, Prakash/AAV-3102-2021; Jogalekar, Manasi/AAG-6925-2020; Khan, Fatima/GQP-2552-2022; Rajendran, Ramya/AAV-6338-2021; Dmello, Crismita/ABE-3901-2022 57194462336; 57195318729; 57205752395; 55151400900; 54393130400; 7202791511 prakashg@knu.ac.kr;abc2000@knu.ac.kr; FRONTIERS IN IMMUNOLOGY FRONT IMMUNOL 1664-3224 13 SCIE IMMUNOLOGY 2022 7.3 21.4 4.89 2025-06-25 117 134 immunotherapy; gene therapy; CAR T-cell therapy; solid cancers; hematologic malignancies CHIMERIC-ANTIGEN-RECEPTOR; CHRONIC LYMPHOCYTIC-LEUKEMIA; BRENTUXIMAB VEDOTIN SGN-35; CYTOKINE RELEASE SYNDROME; ACUTE MYELOID-LEUKEMIA; B-CELL; PHASE-I; ADOPTIVE IMMUNOTHERAPY; ANTITUMOR-ACTIVITY; EXTRACELLULAR VESICLES CAR T-cell therapy; gene therapy; hematologic malignancies; immunotherapy; solid cancers Genetic Therapy; Hematologic Neoplasms; Humans; Immunotherapy, Adoptive; Neoplasms; T-Lymphocytes; B cell maturation antigen; BCG vaccine; biological marker; carcinoembryonic antigen; cyclophosphamide; cytotoxic T lymphocyte antigen 4; epidermal growth factor receptor; fludarabine; gamma interferon; gelatinase A; granzyme B; immune checkpoint inhibitor; intercellular adhesion molecule 1; interleukin 15; interleukin 2; interleukin 7; ipilimumab; mesothelin; sipuleucel T; T lymphocyte receptor; tocilizumab; transcription factor FOXP3; tumor antigen; tumor necrosis factor; acute lymphoblastic leukemia; acute myeloid leukemia; anaplastic large cell lymphoma; antigen presenting cell; antineoplastic activity; B cell leukemia; B cell lymphoma; cancer immunotherapy; CD4+ T lymphocyte; CD8+ T lymphocyte; cell based gene therapy; chimeric antigen receptor T-cell immunotherapy; chronic lymphatic leukemia; colorectal carcinoma; cytokine release syndrome; dendritic cell; diffuse large B cell lymphoma; follicular lymphoma; genetic engineering; glioblastoma; hematologic malignancy; hematopoietic stem cell transplantation; Hodgkin disease; human; immune response; immunocompetent cell; immunotherapy; liver cell carcinoma; macrophage; mantle cell lymphoma; marginal zone lymphoma; metastatic melanoma; minimal residual disease; multiple myeloma; natural killer cell; NF kB signaling; nonhodgkin lymphoma; overall survival; pancreas carcinoma; progression free survival; protein synthesis; Review; T cell lymphoma; T lymphocyte; T lymphocyte activation; triple negative breast cancer; tumor growth; tumor lysis syndrome; tumor microenvironment; upregulation; adoptive immunotherapy; adverse event; gene therapy; genetics; hematologic disease; neoplasm English 2022 2022-07-22 10.3389/fimmu.2022.925985 바로가기 바로가기 바로가기 바로가기
Article Chemical characteristics of heterogeneous lignocellulosic microfines prepared using the glycol ether-organosolv process: dissolution properties in an NaOH-urea aqueous solution In this study, heterogeneous lignocellulosic microfines (LCMFs) with different physicochemical properties were prepared from softwood by adjusting the reaction conditions of a glycol ether-organosolv process. The dissolution properties of heterogeneous LCMFs in an NaOH-urea aqueous solution were evaluated. As the reaction time increased, the yield and residual lignin content decreased. As the amount of chemical solution used to prepare LCMFs increased, more lignin than carbohydrates were removed, but the degree of polymerization (DP) was maintained. Finally, LCMFs with different residual lignin content, DP, and crystallinity were prepared via the glycol ether-organosolv process under various conditions. It was observed that lower the lignin content of heterogeneous LCMFs, higher were their solubilities in the NaOH-urea solution. The effect of DP on solubility was not significant; however, the hemicellulose content of LCMFs had a greater effect on their solubilities in the NaOH-urea aqueous solution than the sugar composition of hemicellulose. The chemical properties of lignin present in LCMFs had no significant effect on their solubilities in the NaOH-urea aqueous solution. Kim, Kang-Jae; Ryu, Ji-Ae; Eom, Tae-Jin Kyungpook Natl Univ, Sch Forestry Sci & Landscape Architecture, Daegu 41566, South Korea; Kyungpook Natl Univ, Agr Sci & Technol Res Inst, Daegu 41566, South Korea; Kyungpook Natl Univ, Dept Wood Sci & Technol, Daegu 41566, South Korea Kim, Kang-Jae/K-3915-2019 35733947500; 57195239379; 13410809400 jaeya0624@knu.ac.kr;jaryu@knu.ac.kr;tjeom@knu.ac.kr; HOLZFORSCHUNG HOLZFORSCHUNG 0018-3830 1437-434X 76 6 SCIE FORESTRY;MATERIALS SCIENCE, PAPER & WOOD 2022 2.4 21.4 0.05 2025-06-25 0 1 degree of polymerization; heterogeneous lignocellulosic microfines; lignin content; NaOH-urea aqueous solution; organosolv process LIGNIN MODEL-COMPOUND; LIQUEFACTION MECHANISM; CELLULOSE; WOOD; PHENOL; PULP; TEMPERATURE; BEHAVIOR; TRENDS degree of polymerization; heterogeneous lignocellulosic microfines; lignin content; NaOH-urea aqueous solution; organosolv process Chemical Properties; Dissolving; Ethers; Ethylene Glycol; Lignin Content; Processes; Residual Lignin; Urea; Cellulose; Crystallinity; Dissolution; Ethers; Glycols; Lignin; Metabolism; Physicochemical properties; Polymerization; Solubility; Urea; Degrees of polymerizations; Glycol ethers; Heterogeneous lignocellulosic microfine; Lignin contents; Ligno-cellulosics; NaOH-urea aqueous solution; Organosolv; Organosolv process; Property; Residual lignins; Sodium hydroxide English 2022 2022-06-27 10.1515/hf-2021-0092 바로가기 바로가기 바로가기 바로가기
Article Effect of Salivary Exosomal miR-25-3p on Periodontitis With Insulin Resistance Periodontitis is caused by an oral microbial dysbiosis-mediated imbalance of the local immune microenvironment, which is promoted by insulin resistance and obesity. The prevalence and severity of periodontitis is higher in patients with type 2 diabetes than in healthy individuals, possibly because of differences in immune responses. The level of glycemic control also affects the saliva profile, which may further promote periodontal disease in diabetes patients. Therefore, we compared the salivary exosomal miRNA profiles of patients with type 2 diabetes with those of healthy individuals, and we found that exosomal miR-25-3p in saliva is significantly enriched (by approximately 2-fold, p < 0.01) in obese patients with type 2 diabetes. We also identified CD69 mRNA as a miR-25-3p target that regulates both activation of gamma delta T cells and the inflammatory response. Knockdown of CD69 increased (by approximately 2-fold) interleukin-17A production of gamma delta T cells in vitro. To evaluate the role of exosomal miRNA on progression of periodontitis, we analyzed regional immune cells in both periodontal tissues and lymph nodes from mice with periodontitis. We found that diet-induced obesity increased the population of infiltrating pro-inflammatory immune cells in the gingiva and regional lymph nodes of these mice. Treatment with miR-25-3p inhibitors prevented the local in vivo inflammatory response in mice with periodontitis and diet-induced obesity. Finally, we showed that suppression of interleukin 17-mediated local inflammation by a miR-25-3p inhibitor alleviated (by approximately 34%) ligature-induced periodontal alveolar bone loss in mice. Taken together, these data suggest that exosomal miR-25-3p in saliva contributes to development and progression of diabetes-associated periodontitis. Discovery of additional miR-25-3p targets may provide critical insights into developing drugs to treat periodontitis by regulating gamma delta T cell-mediated local inflammation. Byun, Jin-Seok; Lee, Ho Yeop; Tian, Jingwen; Moon, Ji Sun; Choi, Jaejin; Lee, Sang-Hee; Kim, Yong-Gun; Yi, Hyon-Seung Kyungpook Natl Univ, Dept Oral Med, Sch Dent, Daegu, South Korea; Chungnam Natl Univ, Dept Med Sci, Sch Med, Daejeon, South Korea; Chungnam Natl Univ, Res Ctr Endocrine & Metab Dis, Sch Med, Daejeon, South Korea; Chungnam Natl Univ, Lab Endocrinol & Immune Syst, Sch Med, Daejeon, South Korea; Panagene Inc, Dept Res & Dev, Daejeon, South Korea; Korea Basic Sci Inst, Bioelect Microscopy Res Ctr Dong 104, Cheongju, South Korea; Kyungpook Natl Univ, Dept Periodontol, Sch Dent, Daegu, South Korea Yi, Hyon-Seung/ABA-2729-2022 55430621800; 57221714890; 57218201812; 57207780661; 57420483300; 58743241400; 55622694400; 55376878100 periokyg@knu.ac.kr;jmpbooks@cnu.ac.kr; FRONTIERS IN IMMUNOLOGY FRONT IMMUNOL 1664-3224 12 SCIE IMMUNOLOGY 2022 7.3 21.4 1.83 2025-06-25 25 22 periodontitis; miRNA; exosome; saliva; diabetes; insulin resistance; inflammation DIABETES-MELLITUS; BIOMARKERS; DISEASE; CD69 diabetes; exosome; inflammation; insulin resistance; miRNA; periodontitis; saliva Adult; Aged; Animals; Diabetes Mellitus, Type 2; Exosomes; Female; Humans; Insulin Resistance; Male; Mice; MicroRNAs; Middle Aged; Periodontitis; Saliva; amyloid beta protein; interleukin 17; microRNA; transcription factor FOXP3; tumor necrosis factor; microRNA; MIRN25 microRNA, human; MIRN25 microRNA, mouse; alveolar bone; animal experiment; animal model; animal tissue; Article; bone density; C57BL 6 mouse; CD4+ T lymphocyte; chow diet; controlled study; diabetes mellitus; diabetic patient; dysbiosis; exosome; flow cytometry; fluorescence activated cell sorting; gene knockdown; glucose blood level; glucose tolerance test; glycemic control; immune response; inflammation; informed consent; insulin resistance; lipid diet; micro-computed tomography; microenvironment; mouse; non insulin dependent diabetes mellitus; nonhuman; obesity; periodontitis; prevalence; regulatory T lymphocyte; synchrotron radiation; Th17 cell; tumor associated leukocyte; adult; aged; animal; exosome; female; human; immunology; insulin resistance; male; middle aged; periodontitis; saliva English 2022 2022-01-07 10.3389/fimmu.2021.775046 바로가기 바로가기 바로가기 바로가기
Article Ensemble inequivalence and negative extensibility in a strongly stretched wormlike chain with fluctuating bending stiffness Many semiflexible polymers exhibit fluctuations in the local bending stiffness along their contour. This may be due to intrinsic conformational changes (e.g., denaturation bubble formation in double stranded DNA or helix-coil transition in polypeptides) or the reversible adsorption and desorption of molecules from the polymer's environment (e.g., DNA-protein interactions or hybridization of oligonucleotides). In this article, we analyze the tensile elasticity of a strongly stretched wormlike chain, which consists of N concatenated segments, where each segment can be in one of two states, A or B, which differ in bending stiffness. We call this model the reversible wormlike chain (rWLC) model. In the Gibbs (fixed-force, isotensional) ensemble, we obtain analytic expressions for the force-extension relation and the mean fraction of B segments. We show that, under certain conditions, there is a tension-induced crossover from a mostly A to a mostly B rWLC. In the Helmholtz (fixed-extension, isometric) ensemble, we obtain analytic expressions up to a summation. We show that, for finite N, there is marked ensemble inequivalence. Remarkably, in the Helmholtz ensemble, the rWLC can exhibit negative extensibility and multiple peaks. Benetatos, Panayotis Kyungpook Natl Univ, Dept Phys, 80 Daehakro, Daegu 41566, South Korea Benetatos, Panayotis/AAT-5957-2021 6507575810 pben@knu.ac.kr; JOURNAL OF CHEMICAL PHYSICS J CHEM PHYS 0021-9606 1089-7690 157 16 SCIE CHEMISTRY, PHYSICAL;PHYSICS, ATOMIC, MOLECULAR & CHEMICAL 2022 4.4 21.4 0.64 2025-06-25 7 7 FREELY JOINTED CHAIN; DNA; TRANSITION; ELASTICITY; EQUIVALENCE; COPOLYMERS; MOLECULES; EXTENSION; BINDING; MODEL DNA; Elasticity; Mechanical Phenomena; Polymers; Stiffness; DNA; polymer; Adsorption and desorptions; Analytic expressions; Bending stiffness; Conformational change; Ensemble inequivalence; Helix-coil transitions; Local bending; Reversible adsorption; Semiflexible polymers; Wormlike chain; chemistry; elasticity; mechanics; Oligonucleotides English 2022 2022-10-28 10.1063/5.0112552 바로가기 바로가기 바로가기 바로가기
Article Epigenetic therapy reprograms M2-type tumor-associated macrophages into an M1-like phenotype by upregulating miR-7083-5p Reprogramming M2-type, pro-tumoral tumor-associated macrophages (TAMs) into M1-type, anti-tumoral macrophages is a key strategy in cancer therapy. In this study, we exploited epigenetic therapy using the DNA methylation inhibitor 5-aza-2'-deoxycytidine (5-aza-dC) and the histone deacetylation inhibitor trichostatin A (TSA), to reprogram M2-type macrophages into an M1-like phenotype. Treatment of M2-type macrophages with the combination of 5-aza-dC and TSA decreased the levels of M2 macrophage cytokines while increasing those of M1 macrophage cytokines, as compared to the use of either therapy alone. Conditioned medium of M2 macrophages treated with the combination of 5-aza-dC and TSA sensitized the tumor cells to paclitaxel. Moreover, treatment with the combination inhibited tumor growth and improved anti-tumor immunity in the tumor microenvironment. Depletion of macrophages reduced the anti-tumor growth activity of the combination therapy. Profiling of miRNAs revealed that the expression of miR-7083-5p was remarkably upregulated in M2 macrophages, following treatment with 5-aza-dC and TSA. Transfection of miR-7083-5p reprogrammed the M2-type macrophages towards an M1-like phenotype, and adoptive transfer of M2 macrophages pre-treated with miR-7083-5p into mice inhibited tumor growth. miR-7083-5p inhibited the expression of colony-stimulating factor 2 receptor alpha and CD43 as candidate targets. These results show that epigenetic therapy upon treatment with the combination of 5-aza-dC and TSA skews M2-type TAMs towards the M1-like phenotype by upregulating miR-7083-5p, which contributes to the inhibition of tumor growth. Vadevoo, Sri Murugan Poongkavithai; Gunassekaran, Gowri Rangaswamy; Yoo, Jae Do; Kwon, Tae-Hwan; Hur, Keun; Chae, Sehyun; Lee, Byungheon Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, Daegu, South Korea; Kyungpook Natl Univ, Cell & Matrix Res Inst CMRI, Daegu, South Korea; Kyungpook Natl Univ, Grad Sch, Dept Biomed Sci, Daegu, South Korea; Korea Brain Res Inst KBRI, Daegu, South Korea Hur, Keun/G-9513-2011; Kwon, Tae-Hwan/ABA-1981-2020 56663280000; 36028043400; 57216203097; 7202206089; 8861888000; 55305469400; 16304374900 leebh@knu.ac.kr; FRONTIERS IN IMMUNOLOGY FRONT IMMUNOL 1664-3224 13 SCIE IMMUNOLOGY 2022 7.3 21.4 1.16 2025-06-25 18 14 5-aza-2'-deoxycytidine; epigenetic therapy; macrophage reprogramming; miR-7083-5p; trichostatin A EXPRESSION; POLARIZATION; RESPONSES; PROGRESSION; ACTIVATION; CANCER; CELLS; CD43 5-aza-2’-deoxycytidine; epigenetic therapy; macrophage reprogramming; miR-7083-5p; trichostatin A Animals; Epigenomics; Mice; Protein Processing, Post-Translational; Transfection; Tumor-Associated Macrophages; arginase 1; beta actin; clodronic acid; colony stimulating factor 2 receptor alpha; decitabine; gamma interferon; inducible nitric oxide synthase; interleukin 10; interleukin 12p40; interleukin 4; interleukin 6; leukosialin; luciferin; membrane protein; microRNA; microRNA 7083 5p; OKT 8; paclitaxel; transforming growth factor beta; trichostatin A; unclassified drug; 3' untranslated region; 4T1 cell line; adoptive transfer; animal cell; animal experiment; animal model; animal tissue; Article; bioluminescence; cancer therapy; CD8+ T lymphocyte; cell viability assay; controlled study; down regulation; enzyme linked immunosorbent assay; epigenetics; female; flow cytometry; genetic transfection; Lewis lung carcinoma cell line; luciferase assay; M2 tumor-associated macrophage; male; microarray analysis; monocyte; mouse; nonhuman; nuclear reprogramming; phenotype; polarization; reverse transcription polymerase chain reaction; tumor growth; tumor immunity; tumor volume; upregulation; animal; protein processing English 2022 2022-11-22 10.3389/fimmu.2022.976196 바로가기 바로가기 바로가기 바로가기
Article Experimental investigation on the thermal appraisal of heat pipe-evacuated tube collector-based water heating system integrated with PCM There is a great deal of research being done on the performance of solar collectors. Evacuated tube solar col-lectors are a mature technology that has proved reassuring performance for heat generation. However, low thermal efficiency remains their main challenge. Therefore, research to improve the efficiency of Evacuated Tube of Solar has continued to date based on some new approaches. The present study presented various designs of Evacuated Tube of Solar collector (ETSC) thermally enhanced by the addition of reflectors and thermal storage units with phase change materials and nanoparticles. The proposed models were assessed during different pe-riods and different zones in Tunisia, especially in the Northern and Southern regions. This work established the energy balance of solar thermal systems determined by the input/output method. Assumptions and mathematical relations are presented for the proposed designs. Additionally, measured and regression useful energy as a function of the daily cumulative global solar energy of all ETSC-types was also evaluated. Research gaps in this field are identified and future research trends and directions are recommended. Bouadila, Salwa; Baddadi, Sara; Rehman, Tauseef-ur; Ayed, Rabeb Ctr Rech & Technol Energie, Technopole Borj Cedria,BP 95, Ben Arous, Tunisia; Kyungpook Natl Univ, Sch Mech Engn, Daegu 41566, South Korea Rehman, Tauseef-ur/AAE-3086-2022; BOUADILA, Salwa/AAP-6218-2020 55710749600; 57205263214; 57159403400; 57875330600 salwa.bouadila@crten.rnrt.tn; RENEWABLE ENERGY RENEW ENERG 0960-1481 1879-0682 199 SCIE ENERGY & FUELS;GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY 2022 8.7 21.4 1.48 2025-06-25 26 30 Energy efficiency; ETSC; Latent heat storage; PCM SOLAR AIR HEATER; PHASE-CHANGE MATERIALS; LONG-TERM PERFORMANCE; ENERGY; STORAGE; ENHANCEMENT; TUNISIA Energy efficiency; ETSC; Latent heat storage; PCM Collector efficiency; Heat pipes; Heat storage; Phase change materials; Solar heating; Solar thermal energy; Tubes (components); Evacuated tube collectors; Evacuated tube of solar collector; Evacuated tube solar collector; Evacuated tubes; Experimental investigations; Latent heat storage; Performance; Thermal; Thermal-efficiency; Water heating systems; energy efficiency; integrated approach; performance assessment; Energy efficiency English 2022 2022-11 10.1016/j.renene.2022.09.004 바로가기 바로가기 바로가기 바로가기
Article Kinetics of vaccine-induced neutralizing antibody titers and estimated protective immunity against wild-type SARS-CoV-2 and the Delta variant: A prospective nationwide cohort study comparing three COVID-19 vaccination protocols in South Korea IntroductionDespite vaccine development, the COVID-19 pandemic is ongoing due to immunity-escaping variants of concern (VOCs). Estimations of vaccine-induced protective immunity against VOCs are essential for setting proper COVID-19 vaccination policy. MethodsWe performed plaque-reduction neutralizing tests (PRNTs) using sera from healthcare workers (HCWs) collected from baseline to six months after COVID-19 vaccination and from convalescent COVID-19 patients. The 20.2% of the mean PRNT titer of convalescent sera was used as 50% protective value, and the percentage of HCWs with protective immunity for each week (percent-week) was compared among vaccination groups. A correlation equation was deduced between a PRNT 50% neutralizing dose (ND50) against wild type (WT) SARS-CoV-2 and that of the Delta variant. ResultsWe conducted PRNTs on 1,287 serum samples from 297 HCWs (99 HCWs who received homologous ChAdOx1 vaccination (ChAd), 99 from HCWs who received homologous BNT162b2 (BNT), and 99 from HCWs who received heterologous ChAd followed by BNT (ChAd-BNT)). Using 365 serum samples from 116 convalescent COVID-19 patients, PRNT ND50 of 118.25 was derived as 50% protective value. The 6-month cumulative percentage of HCWs with protective immunity against WT SARS-CoV-2 was highest in the BNT group (2297.0 percent-week), followed by the ChAd-BNT (1576.8) and ChAd (1403.0) groups. In the inter-group comparison, protective percentage of the BNT group (median 96.0%, IQR 91.2-99.2%) was comparable to the ChAd-BNT group (median 85.4%, IQR 15.7-100%; P =0.117) and significantly higher than the ChAd group (median 60.1%, IQR 20.0-87.1%; P <0.001). When Delta PRNT was estimated using the correlation equation, protective immunity at the 6-month waning point was markedly decreased (28.3% for ChAd group, 52.5% for BNT, and 66.7% for ChAd-BNT). ConclusionDecreased vaccine-induced protective immunity at the 6-month waning point and lesser response against the Delta variant may explain the Delta-dominated outbreak of late 2021. Follow-up studies for newly-emerging VOCs would also be needed. Nham, Eliel; Ko, Jae-Hoon; Song, Kyoung-Ho; Choi, Ju-Yeon; Kim, Eu Suk; Kim, Hye-Jin; Kim, Byoungguk; Lim, Hee-Young; Kim, Kyung-Chang; Jang, Hee-Chang; Lee, Kyoung Hwa; Song, Young Goo; Baek, Yae Jee; Ahn, Jin Young; Choi, Jun Yong; Kim, Yong Chan; Park, Yoon Soo; Choi, Won Suk; Bae, Seongman; Kim, Sung-Han; Kang, Eun-Suk; Jeong, Hye Won; Kim, Shin-Woo; Kwon, Ki Tae; Kim, Sung Soon; Peck, Kyong Ran Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Div Infect Dis,Dept Med, Seoul, South Korea; Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Internal Med, Seongnam, South Korea; Natl Inst Infect Dis, Korea Natl Inst Hlth, Korea Dis Control & Prevent Agcy, Cheongju, South Korea; Yonsei Univ, Gangnam Severance Hosp, Coll Med, Dept Internal Med,Div Infect Dis, Seoul, South Korea; Yonsei Univ, Severance Hosp, Coll Med, Dept Internal Med, Seoul, South Korea; Yonsei Univ, Yongin Severance Hosp, Coll Med, Dept Internal Med,Div Infect Dis, Yongin, South Korea; Korea Univ, Ansan Hosp, Coll Med, Dept Internal Med,Div Infect Dis, Ansan, South Korea; Univ Ulsan, Coll Med, Asan Med Ctr, Dept Infect Dis, Seoul, South Korea; Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med & Genet, Seoul, South Korea; Chungbuk Natl Univ, Coll Med, Dept Internal Med, Div Infect Dis, Cheongju, South Korea; Kyungpook Natl Univ, Sch Med, Dept Internal Med, Dept Internal Med,Div Infect Dis, Daegu, South Korea; Kyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Internal Med,Div Infectious Dis,, Daegu, South Korea Kim, Sang Hyuk/AFE-5646-2022; Choi, Won Suk/V-2730-2017; Kim, Eu/J-5424-2012; Choi, Jah/AAA-4835-2022; Hwang, Soyoon/HHM-5762-2022; Nham, Eliel/AFP-2784-2022; Park, Yoon/C-6472-2015; Kim, Jwa/AAH-9915-2021; Lee, Kyoung-Hwa/AAJ-5213-2021; Peck, Kyong Ran/AGV-5205-2022; Jeong, Hye/AET-1982-2022; Choi, Won/V-2730-2017 57190045330; 55804188300; 23398486700; 57203732512; 22938086900; 59412639300; 57792610600; 58277172200; 52063321200; 7202135138; 56955948100; 55675198500; 57216363310; 57225850337; 57791298700; 36486497700; 7405373036; 56718971800; 57189690904; 55133790400; 20234715300; 13103042700; 8710731500; 9733850500; 57218856689; 55664295200 hwjeong@chungbuk.ac.kr;ksw2kms@knu.ac.kr;ktkwon@knu.ac.kr;sungskim@korea.kr;krpeck@skku.edu; FRONTIERS IN IMMUNOLOGY FRONT IMMUNOL 1664-3224 13 SCIE IMMUNOLOGY 2022 7.3 21.4 1.25 2025-06-25 16 17 protective immunity; vaccination; neutralizing antibody; SARS-CoV-2; COVID-19 COVID-19; neutralizing antibody; protective immunity; SARS-CoV-2; vaccination Antibodies, Neutralizing; Antibodies, Viral; BNT162 Vaccine; Cohort Studies; COVID-19; COVID-19 Vaccines; Humans; Immunization, Passive; Kinetics; Pandemics; Prospective Studies; Republic of Korea; SARS-CoV-2; Vaccination; Viral Vaccines; convalescent serum; neutralizing antibody; nonsteroid antiinflammatory agent; nucleocapsid protein; paracetamol; tozinameran; vaxzevria; neutralizing antibody; virus antibody; virus vaccine; adult; antibody response; antibody titer; arthralgia; Article; body mass; chemoluminescence; chill; cohort analysis; convalescence; coronavirus disease 2019; diarrhea; fatigue; female; fever; follow up; headache; health care personnel; human; immunity; kinetics; major clinical study; male; myalgia; pain; plaque reduction neutralization test; reverse transcription polymerase chain reaction; SARS-CoV-2 Delta; Severe acute respiratory syndrome coronavirus 2; skin redness; South Korea; swelling; vaccination; variant of concern; virus neutralization; vomiting; epidemiology; kinetics; pandemic; passive immunization; prevention and control; prospective study; therapy; vaccination English 2022 2022-09-23 10.3389/fimmu.2022.968105 바로가기 바로가기 바로가기 바로가기
Correction Non-Invasive Diagnosis for Acute Rejection Using Urinary mRNA Signature Reflecting Allograft Status in Kidney Transplantation (vol 12, 656632, 2021) Seo, Jung-Woo; Lee, Yu-Ho; Tae, Dong Hyun; Park, Seon Hwa; Moon, Ju-Young; Jeong, Kyung Hwan; Kim, Chan-Duck; Chung, Byung Ha; Park, Jae Berm; Kim, Yeong Hoon; Seok, Junhee; Joo, Sun Hyung; Lee, Seung Hwan; Lee, Jong Soo; Lee, Sang-Ho Kyung Hee Univ, Med Sci Inst, Core Res Lab, Hosp Gangdong, Seoul, South Korea; Kyung Hee Univ Hosp Gangdong, Dept Internal Med, Div Nephrol, Seoul, South Korea; Korea Univ, Sch Elect Engn, Seoul, South Korea; Kyung Hee Univ, Coll Med, Dept Internal Med, Div Nephrol, Seoul, South Korea; Kyungpook Natl Univ, Dept Internal Med, Div Nephrol, Sch Med, Daegu, South Korea; Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Internal Med,Div Nephrol, Seoul, South Korea; Sungkyunkwan Univ, Dept Surg, Samsung Hosp, Seoul, South Korea; Inje Univ, Coll Med, Dept Internal Med, Div Nephrol,Busan Paik Hosp, Busan, South Korea; Kyung Hee Univ, Dept Surg, Hosp Gangdong, Seoul, South Korea; Univ Ulsan, Dept Internal Med, Div Nephrol, Coll Med, Ulsan, South Korea Moon, Ju-Young/T-6959-2019; Lee, Seung/AAI-1191-2020; Kim, Tae-Hee/AAN-9079-2021; Kim, Hyoungnae/JXN-1329-2024; , Prof/W-5371-2019 56678212900; 56344334200; 57194702774; 57193847481; 7403231326; 8443579300; 8558530700; 57201863822; 13605451500; 7410196419; 24069490100; 25928515100; 55989532800; 57201264463; 55890136000 lshkidney@khu.ac.kr; FRONTIERS IN IMMUNOLOGY FRONT IMMUNOL 1664-3224 12 SCIE IMMUNOLOGY 2022 7.3 21.4 0 2025-06-25 0 0 kidney; transplantation; non-invasive diagnosis; acute rejection; urinary mRNA acute rejection; kidney; non-invasive diagnosis; transplantation; urinary mRNA erratum English 2022 2022-01-06 10.3389/fimmu.2021.825243 바로가기 바로가기 바로가기 바로가기
Article Performance and wake analysis of horizontal axis tidal current turbine using Improved Delayed Detached Eddy Simulation This paper presents the results of hydrodynamic performance and wake assessment for a horizontal axis tidal current turbine. The three-dimensional instantaneous flow field is resolved utilizing the Improved Delayed Detached Eddy Simulation (IDDES) turbulence model and polyhedral mesh. The rotor rotation is simulated by employing the sliding mesh approach. The simulation results using turbulence model of k u Shear Stress Transport are also presented for comparison. The simulated thrust and power coefficients and wake characteristics are validated against published experimental results. It is shown that the performance and wake velocity predicted by IDDES are closer to the experimental values than those predicted by k -u Shear Stress Transport model. In determining the pressure coefficient, only IDDES captures the time-varying fluctuations pertaining to blade generated turbulence. The oscillations in phase-averaged performance coefficients are substantially larger for IDDES because the inflow turbulence in this model is more realistically resolved using Synthetic Eddy Method. The IDDES predicts more detailed vortex structures which has impact on accurate determination of blade pressure distribution, energy dissipation rate and downstream flow field. It is demonstrated that the IDDES model is capable to satisfactorily simulate the hydrodynamics of a horizontal axis tidal current turbine.(c) 2021 Elsevier Ltd. All rights reserved. Faizan, Muhammad; Badshah, Saeed; Badshah, Mujahid; Haider, Basharat Ali Int Islamic Univ Islamabad, Dept Mech Engn, Islamabad 44000, Pakistan; Kyungpook Natl Univ, Sch Mech Engn, Daegu, South Korea Haider, Basharat/B-5887-2015; Faizan, Muhammad/JLK-8272-2023; Badshah, Saeed/H-4346-2018; Haider, Basharat Ali/B-5887-2015; Badshah, Mujahid/AAA-5129-2019 59750394000; 55818414400; 57188694442; 36805990000 faizan_mech@outlook.com;saeed.badshah@iiu.edu.pk;mujahidbadshah@yahoo.com;bahaider@knu.ac.kr; RENEWABLE ENERGY RENEW ENERG 0960-1481 1879-0682 184 SCIE ENERGY & FUELS;GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY 2022 8.7 21.4 0.84 2025-06-25 17 17 Performance; Wake; Polyhedral mesh; IDDES; Horizontal axis tidal turbine MARINE CURRENT TURBINES; WIND TURBINE; BOUNDARY PROXIMITY; TURBULENCE; FLOW; CFD; TECHNOLOGIES; DESIGN; MODELS; SHEAR Horizontal axis tidal turbine; IDDES; Performance; Polyhedral mesh; Wake Energy dissipation; Flow fields; Flow separation; Hydrodynamics; Mesh generation; Ocean currents; Shear flow; Shear stress; Tidal power; Turbines; Turbulence models; Vortex flow; Vorticity; Current turbines; Horizontal axis; Horizontal axis tidal turbine; Improved delayed detached eddy simulations; Performance; Performances analysis; Polyhedral meshes; Shear-stress transport; Tidal currents; Tidal turbines; hydrodynamics; large eddy simulation; performance assessment; three-dimensional modeling; tidal current; turbine; wake; Wakes English 2022 2022-01 10.1016/j.renene.2021.11.107 바로가기 바로가기 바로가기 바로가기
페이지 이동:

논문 데이터 용어 설명

용어 설명
WoS Web of Science. Clarivate Analytics에서 제공하는 학술 데이터베이스입니다. 해당 논문이 WoS에 수록되어 있는지 여부를 표시합니다 (○: 수록됨).
SCOPUS Elsevier에서 제공하는 세계 최대 규모의 초록 및 인용 데이터베이스입니다. 해당 논문이 SCOPUS에 수록되어 있는지 여부를 표시합니다 (○: 수록됨).
Document Type 문헌의 유형을 나타냅니다. Article(원저), Review(리뷰), Proceeding Paper(학회논문), Editorial Material(편집자료), Letter(레터) 등으로 분류됩니다.
Title 논문의 제목입니다.
Abstract 논문의 초록(요약)입니다. 연구의 목적, 방법, 결과, 결론을 간략히 요약한 내용입니다.
Authors 논문의 저자 목록입니다. 공동 저자가 여러 명인 경우 세미콜론(;)으로 구분됩니다.
Affiliation 저자들의 소속 기관 정보입니다. 대학, 연구소, 기업 등 저자가 소속된 기관명이 표시됩니다.
ResearcherID (WoS) Web of Science의 고유 연구자 식별번호입니다. 동명이인을 구분하고 연구자의 업적을 정확하게 추적할 수 있습니다.
AuthorsID (SCOPUS) SCOPUS의 고유 저자 식별번호입니다. 연구자의 모든 출판물을 추적하고 관리하는 데 사용됩니다.
Journal 논문이 게재된 학술지의 정식 명칭입니다.
JCR Abbreviation Journal Citation Reports에서 사용하는 저널의 공식 약어입니다. 저널을 간략하게 표기할 때 사용됩니다.
ISSN International Standard Serial Number. 국제표준연속간행물번호로, 인쇄본 저널에 부여되는 고유 식별번호입니다.
eISSN Electronic ISSN. 전자 버전 저널에 부여되는 고유 식별번호입니다.
Volume 저널의 권(Volume) 번호입니다. 보통 연도별로 하나의 권이 부여됩니다.
Issue 저널의 호(Issue) 번호입니다. 한 권 내에서 여러 호로 나누어 출판되는 경우가 많습니다.
WoS Edition Web of Science의 에디션입니다. SCIE(Science Citation Index Expanded), SSCI(Social Sciences Citation Index), AHCI(Arts & Humanities Citation Index) 등으로 구분됩니다.
WoS Category Web of Science의 주제 분류 카테고리입니다. 저널과 논문이 속한 학문 분야를 나타냅니다.
JCR Year 해당 저널의 JCR(Journal Citation Reports) 지표가 산출된 연도입니다.
IF (Impact Factor) 저널 영향력 지수. 최근 2년간 발표된 논문이 해당 연도에 평균적으로 인용된 횟수를 나타냅니다. 저널의 학술적 영향력을 나타내는 대표적인 지표입니다.
JCR (%) 해당 카테고리에서 저널이 위치하는 상위 백분율입니다. 값이 낮을수록 우수한 저널임을 의미합니다 (예: 5%는 상위 5%를 의미).
FWCI Field-Weighted Citation Impact. 분야별 가중 인용 영향력 지수입니다. 논문이 받은 인용을 동일 분야, 동일 연도, 동일 문헌 유형의 평균과 비교한 값입니다. 1.0이 평균이며, 1.0보다 높으면 평균 이상의 인용을 받았음을 의미합니다.
FWCI UpdateDate FWCI 값이 마지막으로 업데이트된 날짜입니다. FWCI는 인용이 누적됨에 따라 주기적으로 업데이트됩니다.
WOS Citation Web of Science에서 집계된 해당 논문의 총 인용 횟수입니다.
SCOPUS Citation SCOPUS에서 집계된 해당 논문의 총 인용 횟수입니다.
Keywords (WoS) 저자가 논문에서 직접 지정한 키워드입니다. Web of Science에 등록된 저자 키워드 목록입니다.
KeywordsPlus (WoS) Web of Science에서 자동으로 추출한 추가 키워드입니다. 논문의 참고문헌 제목에서 자주 등장하는 단어들로 생성됩니다.
Keywords (SCOPUS) 저자가 논문에서 직접 지정한 키워드입니다. SCOPUS에 등록된 저자 키워드 목록입니다.
KeywordsPlus (SCOPUS) SCOPUS에서 자동으로 추출하거나 추가한 색인 키워드입니다.
Language 논문이 작성된 언어입니다. 대부분 English이며, 그 외 다양한 언어로 작성된 논문이 포함될 수 있습니다.
Publication Year 논문이 출판된 연도입니다.
Publication Date 논문의 정확한 출판 날짜입니다 (년-월-일 형식).
DOI Digital Object Identifier. 디지털 객체 식별자로, 논문을 고유하게 식별하는 영구적인 식별번호입니다. 이를 통해 논문의 온라인 위치를 찾을 수 있습니다.